Meda AB

Type: Company
Name: Meda AB
Nationality: Sweden
Web Address: http://www.meda.se/
Fact Sheet: Fact Sheet for Meda AB
First reported Oct 15 2014 - Updated Oct 15 2014 - 2 reports

MEDA: Nomination committee appointed

Regulatory News:As per specifications set at Meda’s 2014 annual general meeting, anomination committee has been appointed. It consists of:Bert Åke Eriksson, Committee Chairman, Stena Sessan Rederi ABSigieri Diaz Pallavicini, Fidim S.r.l.Evert Carlsson, ... [Published CW 50 Detroit - Oct 15 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

Meda Finalizes Acquisition of Rottapharm

Meda on July 31 reported entering into an agreement to acquire the Italian specialty pharma company Rottapharm. According to a release from Meda, completion of the transaction was subject to certain conditions, including clearance from a number of competition ... [Published Individual.com - Oct 15 2014]
First reported Oct 13 2014 - Updated Oct 13 2014 - 1 reports

Meda finalises EUR2.3bn buy of Italy's Rottapharm

(M&A Navigator via COMTEX News Network) -- 13 October 2014 - Swedish drugmaker Meda AB (STO:MEDA-A) said it had closed its SEK21.2bn (USD2.9bn/EUR2.3bn) acquisition of Italian sector player Rottapharm SpA.The total price for the business comprises SEK15.3bn ... [Published PredictWallStreet - Oct 13 2014]
Entities: Meda (Italy), Italy, Meda AB
First reported Oct 10 2014 - Updated Oct 10 2014 - 3 reports

Derivatives: Anticipated adjustment in Meda due to rights issue (67/14)

The following information is based on a press release from Meda AB (Meda) published on October 10, 2014 and may be subject to change.The board of Meda has proposed that the Extraordinary General Meeting (EGM), scheduled for November 6, 2014, approves ... [Published GlobeNewswire - Oct 10 2014]
First reported Oct 10 2014 - Updated Oct 10 2014 - 5 reports

Notice of Extraordinary General Meeting in Meda Aktiebolag (publ)

Regulatory News: Notice is hereby given that the Extraordinary General Meeting ("EGM") of Meda Aktiebolag, corporate ID 556427-2812 (the "Company"), will be held at 1.00 p.m. on Thursday, November... ... [Published FinanzNachrichten.de - Oct 10 2014]
Entities: Meda AB, Corporate
First reported Oct 10 2014 - Updated Oct 10 2014 - 2 reports

MEDA: Meda’s Acquisition of Rottapharm Completed and the Rights Issue of SEK 2 Billion is Launched

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDA-A) (Pink Sheets:MDABY)·The acquisition of the Italian specialty pharma company Rottapharm has been completed. The total purchase price amounts to SEK 21.2 billion.·As part of the financing ... [Published Business Wire Manufacturing News - Oct 10 2014]
First reported Oct 07 2014 - Updated Oct 07 2014 - 1 reports

MEDA : EVP to Serve as US Country Manager

Meda (US) reported that Ton van't Hullenaar, Executive Vice President, will take on additional responsibility for the company.According to a release from the company, Maria Carell , Executive Vice President North America / Australia , and President Meda ... [Published 4 Traders - Oct 07 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 2 reports

Organizational Change, Meda Inc. (US)

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDA-A) (Pink Sheets:MDABY) Ton van't Hullenaar, Executive Vice President will additionally take on the responsibility for Meda Inc. (US). Maria Carell Executive Vice President North America ... [Published Business Wire Manufacturing News - Oct 02 2014]
First reported Sep 25 2014 - Updated Sep 25 2014 - 1 reports

SADIF Analytics releases new summary due diligence report for Meda AB (MEDA A)

- SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Meda AB (MEDA A) and produced a report, rating the company's attractiveness to long-term investors.Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due ... [Published PR inside - Sep 25 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Sun pharma to raise Rs 120 bn through QIP

Construction Update : Deals| 15 Sep 2014 India’s largest drug maker by value, Sun Pharmaceutical has plan to raise Rs 120 bn through qualified institutional placement (QIP) and is seeking shareholders nod for the same. It also plans to raise Rs 500 bn ... [Published ASAPP - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Sun Pharma rises on plan to raise QIP worth Rs 12,000 crore

Sun Pharmaceutical Industries is currently trading at Rs. 809.00, up by 3.10 points or 0.38% from its previous closing of Rs. 805.90 on the BSE.The scrip opened at Rs. 804.85 and has touched a high and low of Rs. 815.00 and Rs. 804.85 respectively. So ... [Published Arihant Capital - Sep 15 2014]
First reported Sep 11 2014 - Updated Sep 12 2014 - 4 reports

Sun Pharma To Raise Funds Through QIP

India’s largest pharma company by value, @Sun_Pharmaceutical is planning to raise INR 120 Bn through QIP and is seeking shareholders nod for the same.It also planning to raise INR 500 Bn in debt. The end use of huge amount raised is not known, however ... [Published Deal Curry - Sep 12 2014]

Quotes

Report stated that company wanted shareholders approval to "issue, offer and allot equity shares or non-convertible securities, other than warrants."
Sun Pharma stated the company wanted shareholders’ approval to "issue, offer and allot equity shares or non-convertible securities, other than warrants, up to an amount of Rs 12,000 crore ($2 billion), to qualified institutional buyers pursuant to a QIP." It is also considering shareholders' nod for borrowing Rs 50,000 crore
...patient population with substantial unmet need, there's little pricing sensitivity and there is little business case for generic erosion," he said. "If anything, this deal validates the rare disease business model. Depending on how you do the math they could be the No. 2 or No. 3."
...to grow with our expanded offerings in women's health," says Brian Card, executive director of Women's Health and Urology Sales, Mission Pharmacal. "Our experienced women's health sales force is able to help general practitioners and OB/GYNs address a full range of everyday clinical situations."

More Content

All (43) | News (25) | Reports (0) | Blogs (12) | Audio/Video (0) | Fact Sheets (2) | Press Releases (4)
sort by: Date | Relevance
MEDA: Nomination committee appointed [Published CW 50 Detroit - Oct 15 2014]
MEDA: Nomination committee appointed [Published Business Wire Health News - Oct 15 2014]
Meda Finalizes Acquisition of Rottapharm [Published Individual.com - Oct 15 2014]
Meda finalises EUR2.3bn buy of Italy's Rottapharm [Published PredictWallStreet - Oct 13 2014]
Notice of Extraordinary General Meeting in Meda... [Published FinanzNachrichten.de - Oct 10 2014]
Notice of Extraordinary General Meeting in Meda... [Published CNBC - Oct 10 2014]
Derivatives: Anticipated adjustment in Meda due... [Published GlobeNewswire - Oct 10 2014]
Notice of Extraordinary General Meeting in Meda... [Published Nasdaq - Oct 10 2014]
Notice of Extraordinary General Meeting in Meda... [Published Business Wire - Oct 10 2014]
Notice of Extraordinary General Meeting in Meda... [Published Business Wire Health News - Oct 10 2014]
MEDA: Meda’s Acquisition of Rottapharm Complete... [Published Business Wire Manufacturing News - Oct 10 2014]
MEDA: Meda’s Acquisition of Rottapharm Complete... [Published Business Wire Health News - Oct 10 2014]
BRIEF-Meda completes Rottapharm buy, launches 2... [Published Reuters UK - Oct 10 2014]
NOTICE OF EXTRAORDINARY GENERAL MEETING IN MEDA... [Published GlobeNewswire: Acquisitions News - Oct 10 2014]
Meda : acquisition of Rottapharm completed and ... [Published 4 Traders - Oct 10 2014]
MEDA : EVP to Serve as US Country Manager [Published 4 Traders - Oct 07 2014]
Organizational Change, Meda Inc. (US) [Published Business Wire Manufacturing News - Oct 02 2014]
Organizational Change, Meda Inc. (US) [Published Business Wire Health News - Oct 02 2014]
Organizational change, Meda Inc. (US) [Published CisionWire - English - Oct 02 2014]
SADIF Analytics releases new summary due dilige... [Published PR inside - Sep 25 2014]
Sun pharma to raise Rs 120 bn through QIP [Published ASAPP - Sep 15 2014]
Sun Pharma rises on plan to raise QIP worth Rs ... [Published Arihant Capital - Sep 15 2014]
Sun Pharma To Raise Funds Through QIP [Published Deal Curry - Sep 12 2014]
Sun Pharma plans to raise QIP worth Rs 12,000 c... [Published Indian-Commodity - Sep 12 2014]
Sun Pharma seeks shareholders nod for QIP [Published India Infoline - Sep 12 2014]
Sun Pharma seeks shareholders' nod for Rs 12,00... [Published Business Standard India - Sep 11 2014]
Shire Agrees to AbbVie $55B Takeover Offer [Published The Street Latest - Jul 18 2014]
Mission Pharmacal starts promotion of Elestrin ... [Published PharmaBiz - May 31 2014]
Mission Pharmacal Begins Exclusive Promotion of... [Published PR Newswire: General Business - May 29 2014]
Listing of bond loan(s) issued by Meda AB (publ... [Published GlobeNewswire: Acquisitions News - May 21 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
MEDA: Nomination committee appointed [Published Business Wire Health News - Oct 15 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: As per specifications set at Meda’s 2014 annual general meeting, a nomination committee has been appointed. It consists of: Bert Åke Eriksson, Committee Chairman, Stena Sessan Rederi AB Sigieri Diaz ...
Notice of Extraordinary General Meeting in Meda... [Published Business Wire Health News - Oct 10 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Notice is hereby given that the Extraordinary General Meeting (“EGM”) of Meda Aktiebolag, corporate ID 556427-2812 (the “Company”), will be held at 1.00 p.m. on Thursday, November 6, 2014 at Meda’s headquarters ...
MEDA: Meda’s Acquisition of Rottapharm Complete... [Published Business Wire Manufacturing News - Oct 10 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDA-A) (Pink Sheets:MDABY)·The acquisition of the Italian specialty pharma company Rottapharm has been completed. The total purchase price amounts to SEK 21.2 billion.·As part of the financing ...
MEDA: Meda’s Acquisition of Rottapharm Complete... [Published Business Wire Health News - Oct 10 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDA-A) (Pink Sheets:MDABY)·The acquisition of the Italian specialty pharma company Rottapharm has been completed. The total purchase price amounts to SEK 21.2 billion.·As part of the financing ...
Organizational Change, Meda Inc. (US) [Published Business Wire Manufacturing News - Oct 02 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDA-A) (Pink Sheets:MDABY) Ton van't Hullenaar, Executive Vice President will additionally take on the responsibility for Meda Inc. (US). Maria Carell Executive Vice President North America ...
1 2 3

Press Releases

sort by: Date | Relevance
NOTICE OF EXTRAORDINARY GENERAL MEETING IN MEDA... [Published GlobeNewswire: Acquisitions News - Oct 10 2014]
Listing of bond loan(s) issued by Meda AB (publ... [Published GlobeNewswire: Acquisitions News - May 21 2014]
Meda AB (publ) AGM bulletin [Published GlobeNewswire: Advertising News - May 07 2014]
Statement by the Board of Directors of Meda in ... [Published GlobeNewswire: Acquisitions News - Apr 28 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.